Without this pill, lots of people would be dead

0:00-14:27

25 years ago, the FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was designed specifically to treat CML, chronic myeloid leukemia, and it was one of the first targeted cancer therapies available. A quarter century after approval, it’s still being prescribed, as are second, third and fourth-generation drugs that followed in its footsteps. What made it so special – and so effective? Pharmaceutical correspondent Sydney Lupkin walks

Publisher

Short Wave

Published

May 11, 2026

Duration

14 min

Format

Podcast

Category

News · Daily News

Source

RSS feed

SW

Short Wave

@shortwavenpr

#pill #lots #dead

The Nile